Hereditary primary hemochromatosis is caused by a single faulty building block in a gene. This leads to iron overload, which can have serious consequences for organs and joints. In preclinical studies, researchers have already successfully treated this genetic defect using a targeted correction technique known as base editing. They have now further refined their method in the laboratory.
Source: Medical Xpress
